COMMUNIQUÉS West-GlobeNewswire

Todos Medical Receives Notice of Allowance from the USPTO Covering the Early Diagnosis of Lung Cancer Using the Todos Biochemical Infrared Analysis (TBIA)

01/05/2019 - 14:00

REHOVOT, Israel and NEW YORK, May 01, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of cancer [...]

Abeona Therapeutics Reports Preclinical Data Demonstrating Broad Therapeutic Potential of AIM™ Gene Therapy in Retinal Diseases at Association for Research in Vision and Ophthalmology Annual Meeting

01/05/2019 - 14:00

NEW YORK and CLEVELAND, May 01, 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that intravitreal administration of the Company’s [...]

VBI Vaccines Announces First Quarter 2019 Financial Results and Provides Corporate Update

01/05/2019 - 14:00

All four lead pipeline programs progressing towards expected clinical milestones in 2019 Gearing up for top-line data from the pivotal Phase 3 study of Sci-B-Vac®, VBI’s trivalent hepatitis B vaccine, expected mid-year [...]

Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01/05/2019 - 14:00

CAMBRIDGE, Mass., May 01, 2019 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in [...]

IntelGenx Announces Issuance of Second U.S. Patent for Topical Oral Film Technology

01/05/2019 - 14:00

SAINT LAURENT, Quebec, May 01, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that the United States Patent and Trademark Office [...]

Phoenix Life Announces $40 Million Capital Raise in Conjunction with TABOR Family Office Conference

01/05/2019 - 14:00

DENVER, CO, May 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life” or the “Company”), an adaptive healthcare solutions company, today announced that [...]

Tauriga Sciences, Inc. Enters into Distribution Agreement Focused on Tauri-Gum Sales Throughout Northeast Region of USA and Asia

01/05/2019 - 14:00

NEW YORK, NY, May 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Tauriga Sciences, Inc. (OTCQB: TAUG ) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and [...]

Adaptimmune to Provide Clinical and Business Update on Monday May 6th, 2019

01/05/2019 - 14:00

PHILADELPHIA and OXFORDSHIRE, United Kingdom, May 01, 2019 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, will provide a clinical and business update before [...]

Xeris Pharmaceuticals Announces Results From a Phase 1 Study of Its Novel Formulation of Diazepam

01/05/2019 - 14:00

Favorable pharmacokinetic, safety, and tolerability results support continued development of Xeris’ diazepam Phase 2 study to be initiated in 2H2019 CHICAGO, May 01, 2019 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc [...]

Stryker declares a $0.52 per share quarterly dividend

01/05/2019 - 14:00

Kalamazoo, Michigan, May 01, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.52 per share payable on July 31, 2019 to shareholders of record at [...]

Abeona Therapeutics présente des données précliniques démontrant un large potentiel thérapeutique de la thérapie génique AIM™ dans les maladies rétiniennes lors de l'assemblée générale annuelle de l'Association for Research in Vision and Ophthalmology

01/05/2019 - 14:00

NEW YORK et CLEVELAND, 01 mai 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq : ABEO), chef de file totalement intégré dans la thérapie génique et cellulaire, a annoncé aujourd'hui que l'administration [...]

Verrica Pharmaceuticals Announces Participation in Upcoming Investor Conferences

01/05/2019 - 13:47

WEST CHESTER, Pa., May 01, 2019 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a medical dermatology company committed to the development and commercialization of novel treatments that [...]

Nephros to Report First Quarter 2019 Financial Results on May 8, 2019

01/05/2019 - 13:30

SOUTH ORANGE, NJ, May 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, [...]

Marinus Pharmaceuticals Provides Business Update and Reports First Quarter 2019 Financial Results

01/05/2019 - 13:30

Enrollment complete in Magnolia and Amaryllis studies RADNOR, Pa., May 01, 2019 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative [...]

Checkpoint Therapeutics Announces Positive Interim Clinical Results of Anti-PD-L1 Antibody Cosibelimab

01/05/2019 - 13:30

>40% objective response rates observed in first-line non-small cell lung cancer and cutaneous squamous cell carcinoma Well-tolerated safety profile Enrollment ongoing in expansion cohorts intended to support [...]

Translate Bio Announces $47.5 Million Private Placement

01/05/2019 - 13:30

LEXINGTON, Mass., May 01, 2019 (GLOBE NEWSWIRE) -- Translate Bio, Inc. (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat [...]

Otonomy to Participate in SunTrust Robinson Humphrey Life Sciences Summit

01/05/2019 - 13:30

SAN DIEGO, May 01, 2019 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that the company will host [...]

Strongbridge Biopharma plc Reports First Quarter 2019 Financial Results and Provides Corporate Update

01/05/2019 - 13:30

~ Following Type C Meeting with the U.S. Food & Drug Administration (FDA), Strongbridge Plans to Submit its New Drug Application (NDA) for RECORLEV™ (levoketoconazole) in the Third Quarter of 2020; Submission to [...]

Biogen To Present Data At AAN Highlighting Its Innovative Marketed Treatments And Investigational Pipeline Programs For Complex Neurodegenerative Diseases

01/05/2019 - 13:30

Data demonstrate that pre-symptomatic infants with SMA treated with SPINRAZA ® (nusinersen) over three years achieved motor milestones that are more consistent with normal childhood development Late-breaking data expand [...]